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Pulmonary arterial hypertension (PAH) results in 
volume overload of the right heart chambers. Chroni-
cally elevated right atrial pressure causes its remod-
eling and promotes supraventricular arrhythmias [1] 
— a factor of worse prognosis in this group [2].
The subject of the study was a 31-year-old 
man with idiopathic pulmonary hypertension 
with the history radiofrequency (RF) ablation of 
cavo-tricuspid isthmus due to macroreentry atrial 
tachycardias — repeated twice. From the time of 
diagnosis the patient was treated with treprostinil 
and sildenafil. His clinical state remained stable for 
several years in functional class II.
However, a progression of the disease with 
exacerbation of right ventricular failure and re-
currence of atrial tachycardia (Fig. 1A) have been 
observed, in spite of increasing the dose of trepro-
stinil. Recently, routinely performed tests revealed 
factors of worse prognosis: 6-minute walking dis-
tance — 260 m, N-terminal pro B-type natriuretic 
peptide — 7,647 pg/mL; in echocardiography right 
atrium area was 55 cm2 (Fig. 1C); in right heart cath-
eterization: mean pulmonary artery pressure — 
43 mm Hg, mean right atrial pressure — 24 mm Hg, 
cardiac index — 1.6 L/min/m2, blood oxygen 
saturation in pulmonary artery — 59.6%, pulmo-
nary resistance — 19 WU. We considered next 
RF ablation procedure to stop the arrhythmia, but 
there was a strong suspicion that the arrhythmia 
is rather a result than a cause of the patient’s clini-
cal deterioration [2, 3]. Therefore we performed 
balloon atrial septostomy (BAS) to decrease right 
ventricle preload (Fig. 1D). Small decompressive 
hole in the interatrial septum was done stepwise 
using a balloon with a diameter of 4 mm and then 
6 mm. A pressure drop in the right atrium from 
24 mm Hg to 18 mm Hg was achieved with a con-
comitant decrease in oxygen saturation of arterial 
blood to 90% and end-diastolic pressure in the left 
ventricle maintained at the level of 10 mm Hg. 
Mean pulmonary artery pressure fell to 41 mm Hg 
during the procedure. An additional and unexpected 
benefit of this procedure was a restoration of sinus 
rhythm (Fig. 1B), which was maintained for a few 
months following the procedure and the patient’s 
clinical state remained stable.
Ballon atrial septostomy is a known method 
used as a bridge to lung transplantation (LuTX) 
in patients with severe PAH and right ventricular 
failure with elevated right atrial pressure, however 
it may also be used as a palliative treatment for 
patients disqualified from LuTX to prolong their 
lives [4, 5]. In the described case, such a reduction 
of right atrial pressure and sympathetic overactiv-
ity by the means of BAS [6] not only fulfilled the 
abovementioned role, but also showed another 
benefit — a relief from atrial tachycardia, which 
improved the patient’s short-term prognosis [2, 3].
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Figure 1. In a patient with severe pulmonary arterial hypertension; A. Electrocardiogram (ECG) with atrial tachycardia 
before balloon atrial septostomy (BAS); B. ECG with sinus rhythm restored by means of right atrial pressure reduction 
during BAS; C. Echocardiography: 4-chamber view shows severe enlargement of the right heart chambers; D. BAS: 
inflation of a balloon to make a decompressive hole in the interatrial septum; RA — right atrium; LA — left atrium; 
RV — right ventricle; LV — left ventricle.
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